Q5137 Inj, wezlana, sub cu, 1 mg

Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 90 units per day (practitioner), rationale: Prescribing Information